Kentaro Shirahata
Direttore/Membro del Consiglio presso Shire Pharmaceuticals Group
Provenienza dei contatti di primo grado di Kentaro Shirahata
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Shire Global Finance
 Shire Global Finance Finance/Rental/LeasingFinance Part of Takeda Pharmaceutical Co., Ltd., Shire Global Finance is a British financial services company founded in 2005. The company is based in London, UK. Shire Global Finance offers financial services.
2
| Subsidiary | Finance/Rental/Leasing | 2 |
Shire Biopharmaceuticals Holdings
 Shire Biopharmaceuticals Holdings Financial ConglomeratesFinance Founded in 2005, Shire Biopharmaceuticals Holdings is an investment holding British company that is part of Takeda Pharmaceutical Co., Ltd. The company is based in London, UK.
2
| Subsidiary | Financial Conglomerates | 2 |
Shire Pharmaceuticals Group
 Shire Pharmaceuticals Group Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Group is a British company that manufactures and distributes pharmaceutical products. The company is based in London, UK.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Viropharma Ltd.
 Viropharma Ltd. Pharmaceuticals: MajorHealth Technology Viropharma Ltd. manufactures pharmaceutical products. The company was founded on May 14, 2007 and is headquartered in London, the United Kingdom.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Shire Pharmaceutical Development Ltd.
 Shire Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceutical Development Ltd. is a British company that engages in research and development of pharmaceutical products. The company is based in London, UK. Founded in 1990.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Auralis Ltd.
 Auralis Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Auralis Ltd. is a British company that develops and manufactures pharmaceutical products. The company is based in London, UK. The company was founded in 2005 by Simon Peter Bryson. Auralis was acquired by Shire ViroPharma, Inc., part of Takeda Pharmaceutical Co., Ltd. from January 27, 2014 on May 28, 2010 for $28.95 million.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Shire Biotech UK Holdings Ltd.
 Shire Biotech UK Holdings Ltd. Financial ConglomeratesFinance Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.
1
| Subsidiary | Financial Conglomerates | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kentaro Shirahata tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| SHIRE | Pharmaceuticals: Major | Director/Board Member | |
| Erasmus University Rotterdam | College/University | Masters Business Admin | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree | |
Shire Holdings Europe Ltd.
 Shire Holdings Europe Ltd. Financial ConglomeratesFinance Founded in 1996, Shire Holdings Europe Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. and functions as an investment holding British company. The company is based in London, UK. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Shire Pharmaceuticals Services Ltd.
 Shire Pharmaceuticals Services Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2002, Shire Pharmaceuticals Services Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. that manufactures and distributes pharmaceutical products. The company is based in London, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Shire Europe Ltd.
 Shire Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Europe Ltd. is a holding British company that oversees the manufacturing and wholesale distribution of pharmaceutical medicines. The company is based in London, UK. | Pharmaceuticals: Major | Director/Board Member | |
Shire Investments & Finance (U.K.) Co.
 Shire Investments & Finance (U.K.) Co. Financial ConglomeratesFinance Founded in 2001, Shire Investments & Finance (U.K.) Co. is a subsidiary of Takeda Pharmaceutical Co., Ltd. that functions as an investment holding British company. The company is based in London, UK. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Baxalta UK Investments Ltd.
 Baxalta UK Investments Ltd. Medical DistributorsDistribution Services Part of Takeda Pharmaceutical Co., Ltd., Baxalta UK Investments Ltd. wholesales pharmaceutical goods. The company is based in London, UK. | Medical Distributors | Director/Board Member Director/Board Member | |
Confo Therapeutics NV
 Confo Therapeutics NV Pharmaceuticals: MajorHealth Technology Confo Therapeutics NV develops pharmaceutical products. It is a drug discovery company building internal drug discovery programs on GPCRs addressing unmet medical need. The company was founded by Jan Steyaert and Toon Laeremans in June 2015 and is headquartered in Brussels, Belgium. | Pharmaceuticals: Major | Chief Executive Officer | |
Dynacure SA
 Dynacure SA Medical/Nursing ServicesHealth Services Dynacure SA is a clinical-stage company, which engages in developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Its product includes, DYN101, an antisense oligonucleotide, or ASO, designed to be a disease-modifying medicine for treatment of the majority of ntronuclear myopathies patients with multiple mutations in adult and pediatric populations. The company was founded by Belinda Cowling in 2016 and is headquartered in Illikirch-Graffenstaden, France. | Medical/Nursing Services | Chief Executive Officer | |
Baxalta UK Ltd.
 Baxalta UK Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2014, Baxalta UK Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. that manufactures biopharmaceutical products. The company is based in London, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Flamingo Therapeutics BV
 Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Flamingo Therapeutics BV is a Belgian company that specializes in developing RNA-targeted therapies for oncology. The company is based in Leuven, Belgium and was founded by Mike Garrett and Floor Stam. Flamingo is dedicated to delivering therapeutic benefit to patients living with cancer and believes that their programs and approach can successfully address large unmet medical needs where RNA-targeting can be effective. The company's clinical-stage pipeline focuses on targeting undruggable transcription factors and splice variants. The CEO is Stephane van Rooijen. | Miscellaneous Commercial Services | Chief Executive Officer | |
Shire Holdings UK Ltd.
 Shire Holdings UK Ltd. Financial ConglomeratesFinance Founded in 2003, Shire Holdings UK Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. and functions as an investment holding company. The company is based in London, UK. | Financial Conglomerates | Director/Board Member | |
Shire Pharmaceutical Contracts Ltd.
 Shire Pharmaceutical Contracts Ltd. Pharmaceuticals: MajorHealth Technology Shire Pharmaceutical Contracts Ltd. develops medicines for patients with rare diseases. The company was incorporated on June 2, 1986 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Shire Pharmaceuticals Ltd.
 Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 10 |
| Belgio | 4 |
| Irlanda | 2 |
| Paesi Bassi | 2 |
| Francia | 2 |
Settori
| Health Technology | 8 |
| Finance | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 37 |
| Chief Executive Officer | 3 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
| Corporate Officer/Principal | 1 |
Contatti più connessi
- Borsa valori
- Insiders
- Kentaro Shirahata
- Connessioni Società
